Ani Pharmaceuticals Inc
Nasdaq · Healthcare · Pharmaceutical Preparations · Princeton, NJ
ANIP chart
What traders are saying about $ANIP
Latest postsAni Pharmaceuticals Inc news
- ANI Pharmaceuticals: Egetis Therapeutics Acquisition Valued At $560 Million To Expand Rare Disease Business
Pulse 2.0 ·
- Form 4 ANI Pharmaceuticals Inc: Nikhil Lalwani (Director, PRESIDENT & CEO) For: 25 August
Investing.com Canada ·
- Ani Pharmaceuticals CEO Lalwani sells $401,220 in common stock By Investing.com
Investing.com India ·
- Is ANI Pharmaceuticals (ANIP) A Bargain After Its $560m Deal?
Yahoo Finance ·
- ANI Pharmaceuticals (ANIP) Offers $560 Million For Rare Disease Expansion
Yahoo Finance ·
- Should ANI Pharmaceuticals (ANIP) Look Undervalued As Results Land And Revenue Guidance Narrows?
Yahoo Finance ·
- ANI Pharmaceuticals (ANIP) Following Q3 Results And Guidance Trim Is It A Bargain
Simply Wall St ·
- ANI Pharmaceuticals (NASDAQ:ANIP) Stock Gets Price Target Bump from Guggenheim
MarketBeat ·
- Lilly, Hims reach GLP-1 deal; Alnylam sales chief to step down
biopharmadive.com ·
- ANI Pharmaceuticals (ANIP) Stock Looks Fairly Valued On Current Earnings
Simply Wall St ·
- ANI Pharmaceuticals Inc (ANIP) Q3 2026 Earnings Call Highlights: Strong Revenue Growth Offset ...
Yahoo Finance ·
- ANI Pharmaceuticals (NASDAQ:ANIP) Hits New 1-Year Low - Here's What Happened
MarketBeat ·
Ani Pharmaceuticals Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $883.4M | $614.4M | $486.8M | $316.4M |
| Net income | $78.0M | -$19.0M | $19.0M | -$48.0M |
| Diluted EPS | $3.32 | $-1.04 | $0.85 | $-3.05 |
| Total assets (year end) | $1.44B | $1.28B | $904.4M | $760.1M |
| Cash and equivalents (year end) | $285.6M | $144.9M | $221.1M | $48.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Ani Pharmaceuticals Inc
- Ticker
- ANIP (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Princeton, NJ
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1023024
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
Frequently asked questions
What exchange is Ani Pharmaceuticals Inc listed on?
Ani Pharmaceuticals Inc trades on the Nasdaq under the ticker symbol ANIP.
What industry is Ani Pharmaceuticals Inc in?
Ani Pharmaceuticals Inc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Ani Pharmaceuticals Inc headquartered?
Ani Pharmaceuticals Inc's business address on file with the SEC is in Princeton, NJ.
When does Ani Pharmaceuticals Inc's fiscal year end?
Ani Pharmaceuticals Inc's fiscal year ends on December 31.
How much revenue did Ani Pharmaceuticals Inc report?
Ani Pharmaceuticals Inc reported $883.4M in revenue for calendar year 2025, according to its SEC filings.